Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 286.62M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -19.5M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 16.00% |
| Sales | 10.47M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 80.00% |
| Dividend | N/A | Price/Book | 6.08 | EPS next 5Y | - | 52W High Chg | -7.00% |
| Recommedations | - | Quick Ratio | 6.67 | Shares Outstanding | 2.02B | 52W Low Chg | 299.00% |
| Insider Own | 14.25% | ROA | -27.58% | Shares Float | 1.76B | Beta | 2.93 |
| Inst Own | 14.43% | ROE | -42.36% | Shares Shorted/Prior | -/- | Price | 0.14 |
| Gross Margin | 86.95% | Profit Margin | -185.47% | Avg. Volume | 56,575 | Target Price | - |
| Oper. Margin | -270.00% | Earnings Date | Jul 21 | Volume | 33,000 | Change | 7.54% |
About IMPEDIMED LIMITED
ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema, and deliver snapshot of fluid status and tissue composition; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
IMPEDIMED LIMITED News